Skip to main content
OpenTrials

Clinical trial condition

Recurrent Non-small Cell Lung Cancer

Explore clinical trials studying Recurrent Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

69 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Non-small Cell Lung Cancer trial results

Recruiting

Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer

NCT02178163

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • KCI at McLaren Bay Region Bay City, Michigan, United States
  • KCI at Mclaren Bloomfield Hills Bloomfield Hills, Michigan, United States
  • KCI At McLaren Clarkston Clarkston, Michigan, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Completed

A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

NCT04623775

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Local Institution - 0160 Duarte, California, United States
  • Local Institution - 0081 Orange, California, United States
  • Local Institution - 0139 New Haven, Connecticut, United States
  • Local Institution - 0153 Jacksonville, Florida, United States
View all 125 locations
View Trial Details
Completed

Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer

NCT06525246

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • National Hospital Organization Shikoku Cancer Center Matsuyama, Ehime, Japan
  • Kobe City Medical Center General Hospital Kobe, Hyōgo, Japan
  • Hyogo College Of Medicine College Hospital Nishinomiya, Hyōgo, Japan
  • Kitasato University Hospital Sagamihara-shi, Kanagawa, Japan
View all 13 locations
View Trial Details
Completed

Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer

NCT01824901

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Emory University Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Eastern Cooperative Oncology Group (ECOG) Research Base Brookline, Massachusetts, United States
View Trial Details

Related conditions